Cargando…

The relationship between hope, medical expenditure and survival among advanced cancer patients

INTRODUCTION: Among those with advanced illness, higher levels of hope may offer physiological benefits. Yet, greater levels of hope may also encourage aggressive treatments. Therefore, higher levels of hope may lead to greater healthcare utilization, higher expenditure, and longer survival. We test...

Descripción completa

Detalles Bibliográficos
Autores principales: Chay, Junxing, Huynh, Vinh Anh, Cheung, Yin Bun, Kanesvaran, Ravindran, Lee, Lai Heng, Malhotra, Chetna, Finkelstein, Eric Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242009/
https://www.ncbi.nlm.nih.gov/pubmed/37287770
http://dx.doi.org/10.3389/fpsyg.2023.1151976
_version_ 1785054116390633472
author Chay, Junxing
Huynh, Vinh Anh
Cheung, Yin Bun
Kanesvaran, Ravindran
Lee, Lai Heng
Malhotra, Chetna
Finkelstein, Eric Andrew
author_facet Chay, Junxing
Huynh, Vinh Anh
Cheung, Yin Bun
Kanesvaran, Ravindran
Lee, Lai Heng
Malhotra, Chetna
Finkelstein, Eric Andrew
author_sort Chay, Junxing
collection PubMed
description INTRODUCTION: Among those with advanced illness, higher levels of hope may offer physiological benefits. Yet, greater levels of hope may also encourage aggressive treatments. Therefore, higher levels of hope may lead to greater healthcare utilization, higher expenditure, and longer survival. We test these hypotheses among patients with advanced cancer. METHODS: A secondary data analysis from a cross-sectional survey of 195 advanced cancer patients with high mortality risk linked to subsequent healthcare utilization (outpatient, day surgeries, non-emergency admissions), health expenditures, and death records. The survey collected data on hope, measured generally by the Herth Hope Index (HHI) and more narrowly by two questions on illness-related hope. Generalized linear regression and Cox models were used to test our hypotheses. RESULTS: 142 (78%) survey participants died during the period of analysis, with close to half (46%) doing so within a year of the survey. Contrary to expectation, HHI scores did not have a significant association with healthcare utilization, expenditure or survival. Yet, illness-related hope, defined as those who expected to live at least 2 years, as opposed to the likely prognosis of 1 year or less as determined by the primary treating oncologist, had 6.6 more planned hospital encounters (95% CI 0.90 to 12.30) in the 12-months following the survey and 41% lower mortality risk (hazard ratio: 0.59, 95% CI 0.36 to 0.99) compared to those who were less optimistic. Secondary analysis among decedents showed that patients who believed that the primary intent of their treatment is curative, had higher total expenditure (S$30,712; 95% CI S$3,143 to S$58,282) in the last 12 months of life than those who did not have this belief. CONCLUSION: We find no evidence of a relationship between a general measure of hope and healthcare utilization, expenditure, or survival among advanced cancer patients. However, greater illness-related hope is positively associated with these outcomes.
format Online
Article
Text
id pubmed-10242009
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102420092023-06-07 The relationship between hope, medical expenditure and survival among advanced cancer patients Chay, Junxing Huynh, Vinh Anh Cheung, Yin Bun Kanesvaran, Ravindran Lee, Lai Heng Malhotra, Chetna Finkelstein, Eric Andrew Front Psychol Psychology INTRODUCTION: Among those with advanced illness, higher levels of hope may offer physiological benefits. Yet, greater levels of hope may also encourage aggressive treatments. Therefore, higher levels of hope may lead to greater healthcare utilization, higher expenditure, and longer survival. We test these hypotheses among patients with advanced cancer. METHODS: A secondary data analysis from a cross-sectional survey of 195 advanced cancer patients with high mortality risk linked to subsequent healthcare utilization (outpatient, day surgeries, non-emergency admissions), health expenditures, and death records. The survey collected data on hope, measured generally by the Herth Hope Index (HHI) and more narrowly by two questions on illness-related hope. Generalized linear regression and Cox models were used to test our hypotheses. RESULTS: 142 (78%) survey participants died during the period of analysis, with close to half (46%) doing so within a year of the survey. Contrary to expectation, HHI scores did not have a significant association with healthcare utilization, expenditure or survival. Yet, illness-related hope, defined as those who expected to live at least 2 years, as opposed to the likely prognosis of 1 year or less as determined by the primary treating oncologist, had 6.6 more planned hospital encounters (95% CI 0.90 to 12.30) in the 12-months following the survey and 41% lower mortality risk (hazard ratio: 0.59, 95% CI 0.36 to 0.99) compared to those who were less optimistic. Secondary analysis among decedents showed that patients who believed that the primary intent of their treatment is curative, had higher total expenditure (S$30,712; 95% CI S$3,143 to S$58,282) in the last 12 months of life than those who did not have this belief. CONCLUSION: We find no evidence of a relationship between a general measure of hope and healthcare utilization, expenditure, or survival among advanced cancer patients. However, greater illness-related hope is positively associated with these outcomes. Frontiers Media S.A. 2023-05-23 /pmc/articles/PMC10242009/ /pubmed/37287770 http://dx.doi.org/10.3389/fpsyg.2023.1151976 Text en Copyright © 2023 Chay, Huynh, Cheung, Kanesvaran, Lee, Malhotra and Finkelstein. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychology
Chay, Junxing
Huynh, Vinh Anh
Cheung, Yin Bun
Kanesvaran, Ravindran
Lee, Lai Heng
Malhotra, Chetna
Finkelstein, Eric Andrew
The relationship between hope, medical expenditure and survival among advanced cancer patients
title The relationship between hope, medical expenditure and survival among advanced cancer patients
title_full The relationship between hope, medical expenditure and survival among advanced cancer patients
title_fullStr The relationship between hope, medical expenditure and survival among advanced cancer patients
title_full_unstemmed The relationship between hope, medical expenditure and survival among advanced cancer patients
title_short The relationship between hope, medical expenditure and survival among advanced cancer patients
title_sort relationship between hope, medical expenditure and survival among advanced cancer patients
topic Psychology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242009/
https://www.ncbi.nlm.nih.gov/pubmed/37287770
http://dx.doi.org/10.3389/fpsyg.2023.1151976
work_keys_str_mv AT chayjunxing therelationshipbetweenhopemedicalexpenditureandsurvivalamongadvancedcancerpatients
AT huynhvinhanh therelationshipbetweenhopemedicalexpenditureandsurvivalamongadvancedcancerpatients
AT cheungyinbun therelationshipbetweenhopemedicalexpenditureandsurvivalamongadvancedcancerpatients
AT kanesvaranravindran therelationshipbetweenhopemedicalexpenditureandsurvivalamongadvancedcancerpatients
AT leelaiheng therelationshipbetweenhopemedicalexpenditureandsurvivalamongadvancedcancerpatients
AT malhotrachetna therelationshipbetweenhopemedicalexpenditureandsurvivalamongadvancedcancerpatients
AT finkelsteinericandrew therelationshipbetweenhopemedicalexpenditureandsurvivalamongadvancedcancerpatients
AT chayjunxing relationshipbetweenhopemedicalexpenditureandsurvivalamongadvancedcancerpatients
AT huynhvinhanh relationshipbetweenhopemedicalexpenditureandsurvivalamongadvancedcancerpatients
AT cheungyinbun relationshipbetweenhopemedicalexpenditureandsurvivalamongadvancedcancerpatients
AT kanesvaranravindran relationshipbetweenhopemedicalexpenditureandsurvivalamongadvancedcancerpatients
AT leelaiheng relationshipbetweenhopemedicalexpenditureandsurvivalamongadvancedcancerpatients
AT malhotrachetna relationshipbetweenhopemedicalexpenditureandsurvivalamongadvancedcancerpatients
AT finkelsteinericandrew relationshipbetweenhopemedicalexpenditureandsurvivalamongadvancedcancerpatients